NCT06950034
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06950034
Title A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Solu Therapeutics, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University RECRUITING Stanford California 94305 United States Details
Moffitt RECRUITING Tampa Florida 12902 United States Details
DFCI RECRUITING Boston Massachusetts 02215 United States Details
Mayo Clinic RECRUITING Rochester Minnesota 55905 United States Details
OHSU RECRUITING Portland Oregon 97239 United States Details
Vanderbilt University NOT_YET_RECRUITING Nashville Tennessee 37232 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field